ESC 365 - Prognostic value of novel heart failure biomarkers in patients undergoing cardiac resynchronization therapy

ESC Premium Access

Prognostic value of novel heart failure biomarkers in patients undergoing cardiac resynchronization therapy

Session: Poster session 7 - Tools to reduce ventricular arrhythmic in cardiac resynchronisation therapy patients and miscellaneous

Topic: Resynchronisation therapy

Speaker: Doctor P. Perge (Budapest, HU)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Peter Perge

Semmelweis University, Budapest (Hungary)

1 presentation

0 follower

19 more presentations in this session

Acute correction of left ventricular preejection interval: an attractive target for cardiac resynchronisation therapy

Speaker: Professor F. Anselme (Rouen, FR)

Procedural feasibility and importance of DF-1 lead in patients undergoing down-grade from cardiac resynchronization therapy with defibrillator

Speaker: Doctor M. Ogano (Shizuoka, JP)

Usefulness of cardiac magnetic resonance for visualization of the coronary sinus ostium and Thebesian valve

Speaker: Associate Professor A. Mlynarska (Katowice, PL)

Long-term cardiac resynchronization therapy reduces T-wave alternans in patients with cardiomyopathy

Speaker: Doctor S. Nayyar (Adelaide, AU)

Are acute phase QRS and cardiac output measurements good predictors of triple-site pacing cardiac resynchronization therapy in permanent atrial fibrillation?

Speaker: Professor G. Lima Da Silva (Lisbon, PT)

Access the full session

Poster session 7 - Tools to reduce ventricular arrhythmic in cardiac resynchronisation therapy patients and miscellaneous

Speakers: Doctor P. Perge, Professor F. Anselme, Doctor M. Ogano, Associate Professor A. Mlynarska, Doctor S. Nayyar...

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources